According to the Robert Koch Institute (RKI), the norovirus, which is widespread worldwide, is the cause of a large proportion of gastrointestinal infections. Those who catch the virus suffer from nausea, diarrhea and vomiting. It is very contagious and can spread quickly from person to person.
There is not much that can be done preventively beyond general hygiene rules. There is currently no vaccine against the norovirus. However, doctors have now begun to test the world’s first mRNA vaccine against the norovirus.
Norovirus vaccine based on mRNA technology is being tested
The vaccine is to undergo a phase three clinical trial called Nova 301. In two years, 25,000 people, mainly over 60 years old, from countries such as Japan, Canada and Australia are to be involved, reports the Guardian. Mobile teams are also to be used to make it easier for people to participate in the trial.
Half of the participants are to receive the new mRNA vaccine and the other half a saline solution as a placebo. The assignment follows at random.
Various institutions of the British National Health Service (NHS) and the pharmaceutical company Moderna, which manufactures the vaccine, are involved in the study. The norovirus vaccine is based on an mRNA technology with which the company Moderna, but also Pizer/Biontech, have already produced a vaccine against the corona virus.
In an earlier trial with the new norovirus vaccine, strong immune reactions are said to have already been detected in humans. The study is now about investigating whether the vaccine is effective against the virus itself and, if so, how long the protection lasts. “At least 65 percent (efficacy) or more is what we would consider clinically sensible,” the Guardian quotes Dr. Doran Fink of Moderna.
Norovirus is a threat to old and sick people
Norovirus outbreaks are common in hospitals, nursing homes, daycare centers or schools. Especially for very young or old people and for anyone who has a weakened immune system, an infection can have serious consequences. A successful vaccine would help ensure that operations in nursing homes could be maintained normally, says Prof. Saul Faust of the University of Southampton, according to the report.
General practitioner and study leader Dr. Patrick Moore emphasizes how high the burden of norovirus is. Worldwide, there are about 685 million cases and 200,000 deaths every year. In the UK, there are about four million cases a year.
It is hoped that a vaccine could bring health and economic benefits. “In the UK, norovirus costs the NHS an estimated £100 million a year [and] if you take into account the loss of earnings, it’s about £300 million,” says Moore.
If the result of the study is positive, it is expected that it will be possible to submit an application for approval for the vaccine in 2026. However, the review process would take another up to a year. In addition, further studies on teenagers and younger people would be needed.
News
New study suggests a way to rejuvenate the immune system
Stimulating the liver to produce some of the signals of the thymus can reverse age-related declines in T-cell populations and enhance response to vaccination. As people age, their immune system function declines. T cell [...]
Nerve Damage Can Disrupt Immunity Across the Entire Body
A single nerve injury can quietly reshape the immune system across the entire body. Preclinical research from McGill University suggests that nerve injuries may lead to long-lasting changes in the immune system, and these [...]
Fake Science Is Growing Faster Than Legitimate Research, New Study Warns
New research reveals organized networks linking paper mills, intermediaries, and compromised academic journals Organized scientific fraud is becoming increasingly common, ranging from fabricated research to the buying and selling of authorship and citations, according [...]
Scientists Unlock a New Way to Hear the Brain’s Hidden Language
Scientists can finally hear the brain’s quietest messages—unlocking the hidden code behind how neurons think, decide, and remember. Scientists have created a new protein that can capture the incoming chemical signals received by brain [...]
Does being infected or vaccinated first influence COVID-19 immunity?
A new study analyzing the immune response to COVID-19 in a Catalan cohort of health workers sheds light on an important question: does it matter whether a person was first infected or first vaccinated? [...]
We May Never Know if AI Is Conscious, Says Cambridge Philosopher
As claims about conscious AI grow louder, a Cambridge philosopher argues that we lack the evidence to know whether machines can truly be conscious, let alone morally significant. A philosopher at the University of [...]
AI Helped Scientists Stop a Virus With One Tiny Change
Using AI, researchers identified one tiny molecular interaction that viruses need to infect cells. Disrupting it stopped the virus before infection could begin. Washington State University scientists have uncovered a method to interfere with a key [...]
Deadly Hospital Fungus May Finally Have a Weakness
A deadly, drug-resistant hospital fungus may finally have a weakness—and scientists think they’ve found it. Researchers have identified a genetic process that could open the door to new treatments for a dangerous fungal infection [...]
Fever-Proof Bird Flu Variant Could Fuel the Next Pandemic
Bird flu viruses present a significant risk to humans because they can continue replicating at temperatures higher than a typical fever. Fever is one of the body’s main tools for slowing or stopping viral [...]
What could the future of nanoscience look like?
Society has a lot to thank for nanoscience. From improved health monitoring to reducing the size of electronics, scientists’ ability to delve deeper and better understand chemistry at the nanoscale has opened up numerous [...]
Scientists Melt Cancer’s Hidden “Power Hubs” and Stop Tumor Growth
Researchers discovered that in a rare kidney cancer, RNA builds droplet-like hubs that act as growth control centers inside tumor cells. By engineering a molecular switch to dissolve these hubs, they were able to halt cancer [...]
Platelet-inspired nanoparticles could improve treatment of inflammatory diseases
Scientists have developed platelet-inspired nanoparticles that deliver anti-inflammatory drugs directly to brain-computer interface implants, doubling their effectiveness. Scientists have found a way to improve the performance of brain-computer interface (BCI) electrodes by delivering anti-inflammatory drugs directly [...]
After 150 years, a new chapter in cancer therapy is finally beginning
For decades, researchers have been looking for ways to destroy cancer cells in a targeted manner without further weakening the body. But for many patients whose immune system is severely impaired by chemotherapy or radiation, [...]
Older chemical libraries show promise for fighting resistant strains of COVID-19 virus
SARS‑CoV‑2, the virus that causes COVID-19, continues to mutate, with some newer strains becoming less responsive to current antiviral treatments like Paxlovid. Now, University of California San Diego scientists and an international team of [...]
Lower doses of immunotherapy for skin cancer give better results, study suggests
According to a new study, lower doses of approved immunotherapy for malignant melanoma can give better results against tumors, while reducing side effects. This is reported by researchers at Karolinska Institutet in the Journal of the National [...]
Researchers highlight five pathways through which microplastics can harm the brain
Microplastics could be fueling neurodegenerative diseases like Alzheimer's and Parkinson's, with a new study highlighting five ways microplastics can trigger inflammation and damage in the brain. More than 57 million people live with dementia, [...]
